A case study of t(14;22)(q32;q11) involving immunoglobulin heavy and light chain in follicular lymphoma.

Shori Abe, Hiroki Katsushima, Fumiyoshi Fujishima, Jun Nomura, Junichi Kameoka, Ryo Ichinohasama

Open access · greenAbstract readCase Reports

In one paragraph

Article in International journal of clinical and experimental pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

–field-weighted citation impact, top 72% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

t(14;22)(q32;q11) translocation involving IGH and IGL acquired at progression of splenic marginal zone lymphoma treated with rituximab, ibrutinib, and obinutuzumab.Annals of hematology · 2025
Article
Role of topical and systemic immunosuppression in aqueous-deficient dry eye disease.Indian journal of ophthalmology · 2023
Review

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Shori AbeDepartment of Hematology, Tohoku Medical and Pharmaceutical University Wakabayashi Hospital Sendai, Japan.

Hiroki KatsushimaDivision of Hematopathology, Tohoku University Hospital Japan.

Fumiyoshi FujishimaDepartment of Anatomic Pathology, School of Medicine, Tohoku University Graduate Japan.

Jun NomuraDepartment of Hematology, Tohoku Medical and Pharmaceutical University Wakabayashi Hospital Sendai, Japan.

Junichi KameokaDivision of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University Japan.

Ryo IchinohasamaDivision of Hematopathology, Tohoku University Hospital Japan.

Tohoku University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chromosome 14 is the most frequently rearranged chromosome in non-Hodgkin lymphoma (NHL), with aberrations particularly involving the heavy-chain immunoglobulin gene (

Indexed as

aplastic anemiacyclosporine AFollicular lymphomatranslocation t(14;22)(q32;q11)

Identifiers

PMID31938130

PMCPMC6957971

OpenAlexW3008319349

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.